Outpatient Risk Identification and Stratification for Opioid Misuse
This course explores the risk factors for opioid misuse and reviews the classification of opioid use disorder. It also provides an overview of assessment and management tools and strategies that can be employed to ensure safe and effective pain management for patients using opioid medications.
This course explores the risk factors for opioid misuse and reviews the classification of opioid use disorder. It also provides an overview of assessment and management tools and strategies that can be employed to ensure safe and effective pain management for patients using opioid medications.
Accreditation Council for Continuing Medical Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Relias LLC designates this enduring activity for a maximum of 0.75 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 0.75 Nursing Contact Hours after successfully completing this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.75 contact hours for participating in this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.7000 contact hours for participating in this course.
Florida Board of Medicine
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 0.75 AMA PRA category 1 Credits™.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 0.75 AMA PRA category 1 Credits™.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 0.75 AMA PRA category 1 Credits™.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
New Mexico Medical Board
Physicians will receive 0.75 AMA PRA category 1 Credits™.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 0.75 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 0.75 AMA PRA category 1 Credits™
Recognize the prevalence of and risk factors for opioid misuse.
Identify three evidence-based assessment tools to determine risks for individual patients
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: The Opioid Epidemic
Meet Josephine
Prevalence of Opioid Use
Opioid Misuse and Opioid Use Disorder
Review
Summary
Section 3: Risk Assessment
Identifying Risk Factors for OUD
Prescribing Guidelines
Avoiding Overdose and Other Opioid-related Harms
Review
Summary
Section 4: Opioid-Specific Risk Assessment in Practice
The Opioid Risk Tool (ORT)
The SOAPP®-R
Review
Summary
Section 5: Conclusion
Course Summary
Course Contributors
Resources
References
Subject Matter Expert: Daisy Goodman, DNP, MPH, APRN, CNMClaire Hartman is a Lead SME writer in Obstetrics for Clinical Solutions at Relias. She has a clinical background in both high-risk obstetrics at a large teaching hospital and in a free-standing community birth center. She has a passion for supporting families experiencing perinatal loss and has led a community support group for bereaved families.
Daisy Goodman, DNP, MPH, APRN, CNM, is a certified nurse midwife and Clinical Assistant Professor of Obstetrics and Gynecology at the Geisel School of Medicine at Dartmouth. She currently directs women's health services at the Dartmouth Hitchcock Moms in Recovery Program and teaches healthcare quality improvement at The Dartmouth Institute. Her research focuses on improving access to substance use treatment for women through integrated delivery models and the intersection between women's healthcare and treatment for substance use. She was one of thefirst wave of advanced practice nurses in New Hampshire to obtain a waiver to prescribe buprenorphine. She currently leads a three -year dissemination and implementation project to improve maternity care for women with opioid use disorders, sponsored by the Northern New England Perinatal Quality Improvement Network.
The target audience for this course is: Nurses; Physician Assistants; Physicians; in the following settings: All Healthcare Settings.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
